AbbVie’s glioblastoma multiforme therapy receives orphan drug designation
AbbVie has obtained orphan drug designation from the European Medicines Agency (EMA) and the US FDA for its anti-epidermal growth…
All articles by Mekala ShivaramPrasad
Mekala ShivaramPrasad
-
-
Alexion receives orphan drug designation for Soliris in Europe
The European Commission has granted orphan drug designation to Alexion Pharmaceuticals' Soliris (eculizumab), a terminal complement inhibitor, to treat patients…
-
Bristol-Myers Squibb and Allied Minds form new research enterprise
Bristol-Myers Squibb and Allied Minds have formed a new jointly owned enterprise, Allied-Bristol Life Sciences, aimed at advancing discoveries of…
-
Vertex obtains receives European approval for cystic fibrosis oral medicine
The European Commission has approved Vertex Pharmaceuticals' oral medicine Kalydeco (ivacaftor) for people with cystic fibrosis (CF).Kalydeco is for CF…
-
FDA approves Jardiance tablets for type 2 diabetes
The US Food and Drug Administration (FDA) has approved Jardiance (empagliflozin) tablets, developed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly…
-
Pfizer to acquire Baxter’s portfolio of marketed vaccines for $635m
Pfizer and Baxter have entered into a definitive agreement under which Pfizer will acquire Baxter's portfolio of marketed vaccines for…
-
Meda agrees to acquire Rottapharm for €2.3bn
Swedish drugmaker Meda has agreed to acquire Italy-based Rottapharm Madaus for around €2.3bn as part of its strategy to boost…
-
FDA approves Bayer’s Eylea to treat diabetic macular edema
Bayer has announced the US Food and Drug Administration's (FDA) approval of Eylea, an aflibercept solution for injection into the…
-
AstraZeneca to have rights of Almirall’s respiratory franchise
Spain-based Almirall and AstraZeneca have entered into an agreement, involving Almirall transfering the rights to its respiratory franchise to Astrazeneca…
-
EMA committee recommends approval of Gilead Sciences’ Zydelig
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on Gilead…